___

• 1. Zu ZY, Jiang MD, Xu PP, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology, 2020;296(2), E15-E25. https://doi.org/10.1148/radiol.2020200490
• 2. WHO Coronavirus Diseade Dashboard. https://covid19.who.int/ , Erişim: 10.12.2022
• 3. Ahmadpoor P, Rostaing L. Why the immune system fails to mount an adaptive immune response to a Covid‐19 infection. Transplant International, 2020;33 (7), 824-825.
• 4. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S. Coronavirus Disease 2019 –COVID-19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405836/pdf/CMR.00028-20.pdf. Erişim: 03.01.2021
• 5. Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290769/pdf/jcm-09-01417.pdf. Erişim: 03.01.2021
• 6. Zhou F, Yu T, Du R, Fan G, Liu Y. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 2020; 395(10229): 1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
• 7. Cheng Y, Luo R, Wang K, Zhang M, Wang Z. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int, 2020; 97(5): 829–38. https://doi.org/10.1016/j.kint.2020.03.005
• 8. Richardson S, Hirsch JS, Narasimhan M, et al. Northwell COVID-19 Research Consortiu. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
• 9. Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR. Extra-respiratory manifestations of COVID-19. International Journal of Antimicrobial Agents, 2020; 56(2), 106024. Int J Antimicrob Agents 2020 Aug;56(2):106024. doi: 10.1016/j.ijantimicag.2020.106024.
• 10. Li Z, Wu M, Guo J, Yao J, Liao X. Caution on Kidney Dysfunctions of 2019-nCoV Patients, medRxiv. 2020 doi: 10.1101/2020.02.08.20021212.
• 11. Topbaş E. Covid-19 Sürecinde Böbrek Yetmezliği Olan Hastanın Yoğun Bakım Yönetimi. Yoğun Bakım Hemşireliği Dergisi, 2020;24(EK-1):61-67.
• 12. Report-COVID-2019_20_marzo_eng.pdf (iss.it) Erişim: 19/04/2023.
• 13. Dhama K, Khan S, Tiwari R, et al. Coronavirus Disease 2019 –COVID, Clin Microbiol Rev., 2020 Jun 24;33(4):e00028-20. doi: 10.1128/CMR.00028-20.
• 14. Yalameha B, Roshan B, Bhaskar L, Mohmoodnia L. Perspectives on the relationship of renal disease and coronavirus disease, Journal of Nephropharmacology, 2019;9(2), e22-e22. doi: 10.34172/npj.2020.22
• 15. Pan XW, Xu D, Zhang H, Zhou W, Wang LH. Identification of a potential mechanism of acute kidney injury during the COVID‐19 outbreak: a study based on single‐cell transcriptome analysis. Intensive Care Med, 2020;1‐3. doi.org/10.1007/s00134-020-06026-1.
• 16. Malha L, Mueller FB, Pecker MS, Mann SJ, August P. COVID‐19 and the renin‐angiotensin system. Kidney Int Rep, 2020;5:563‐565. doi: 10.1016 / j.ekir.2020.03.024.
• 17. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal, 2020;10(2):102-108. doi.org/10.1080/07391102.2020.1772108
• 18. Pei G, Zhang Z, Peng J, 4 Liu L, Zhang C. Renal involvement and early prognosis in patients with COVID‐19 pneumonia. J Am Soc Nephrol, 2020;31(6),1157‐1165. https://doi.org/10.1681/asn.2020030276.
• 19. Mangalmurti N, Hunter CA. Cytokine storms: understanding COVID‐19. Immunity, 2020;53(1),19‐25. https://doi.org/10.1016/j.immuni.2020.06.017.
• 20. Li H, Liu L, Zhang D, Xu J, Dai H. SARS‐CoV‐2 and viral sepsis: observations and hypotheses. The Lancet, 2020;395, 1517‐1520. https://doi.org/10.1016/s0140-6736(20)30920-x.
• 21. Ronco C, Reis T. Kidney involvement in COVID‐19 and rationale for extracorporeal therapies. Nat Rev Nephrol, 2020;16, 308‐310. https://doi.org/10.1038/s41581-020-0284-7.
• 22. Farouk SS, Fiaccadori E, Cravedi P, Campbell VN. COVID 19 and the kidney: what we think we know so far and what we don’t. Journal of Nephrology, 2020;33:1213-1218. https://doi.org/10.1007/s40620-020-00789-y.
• 23. Yang X, Tian S, Guo H. Acute kidney injury and renal replacement therapy in COVID-19 patients: A systematic review and meta-analysis. International Immunopharmacology, 2021; 90, 107159, https://doi.org/10.1016/j.intimp.2020.107159.
• 24. Zheng X, Zhao Y, Yang L. Acute Kidney Injury in COVID-19: The Chinese Experience. Seminarsin nephrology, 2020; (Vol. 40, No. 5, pp. 430-442). https://doi.org/10.1016/j.semnephrol.2020.09.001
• 25. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The lancet respiratory medicine, 2020;8(5), 475-481.https ://doi.org/10.1016/S2213 -2600(20)30079 -5
• 26. Fei Z, Tin, Y, Ronghui D, et al. (Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020; 395(10229), 1054-1062. https ://doi.org/10.1016/S0140-6736(20)30566 -3
• 27. Gabarre P, Dumas G, Dupont T, et al. Acute kidney injury in critically ill patients with COVID-19. Intensive care medicine, 46, 1339-1348. https://doi.org/10.1007/s00134-020-06153-9.
• 28. Cheng Y, Luo R, Wang K, Zhang M, Wang Z. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney International, 2020;97, 829–838. https://doi.org/10.1016/j.kint.2020.03.005.
• 29. Ahmed AR, Ebad CA, Stoneman S, Satti MM, Conlon PJ. Kidney injury in COVID-19. World J Nephrol, 2020; 9(2): 18-32. 10.5527 / wjn.v9.i2.18.
• 30. Adapa S, Aeddula NR, Konala VM, Chennad A, Naramalaf S. COVID-19 and renal failure: challenges in the delivery of renal replacement therapy. J Clin Med Res, 2020;12(5):276-85. doi: 10.14740 / jocmr4160
• 31. Lala A, Johnson KW, Januzzi JL, et al. Mount Sinai COVID Informatics Center. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. Journal of the American college of cardiology, 2020;76(5), 533-546. doi: 10.1681 / ASN.2020050615.
• 32. Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH. Acute kidney injury in patients hospitalized with COVID-19. Kidney International, 2020;98,209–218. https://doi.org/10.1016/ j.kint.2020.05.006
• 33. Adapa S, Aeddula NR, Konala VM, Chennad A, Naramalaf S. COVID-19 and renal failure: challenges in the delivery of renal replacement therapy. J Clin Med Res, 2020;12(5):276-85. doi: 10.14740 / jocmr4160
• 34. Enç N. İç Hastalıkları Hemşireliği, Nobel Tıp Kitapevi İstanbul; 2017, s.229-258.
• 35. https://www.nefroloji.org.tr/folders/file/kitap/temel_nefroloji_2019.pdf Erişim:08.12.2022
• 36. Alp E. Enfeksiyon Hastalıkları, Nobel Tıp Kitapevi, İstanbul; 2013. s. 469.
• 37. Enç N, Can G. İç Hastalıkları Hemşireliği Uygulama Öğrenci Eğitim Modülü, Nobel Tıp Kitapevi, İstanbul; 2015. s.12.
• 38. Ovayolu Ö, Ovayolu N. Akut Böbrek Yetmezliği ve Hemşirelik Yaklaşımı. Nefroloji Hemşireliği Dergisi, 2011; 8(1): 1-5.
• 39. Ulu S, Kazan S, Güngör Ö. Hipotansiyon Tedavisi: Doğru Bilinen Yanlışlar ve Vazopressör Ajanların Güncellenmesi. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi, 2020; 15(1), 52-57.
• 40. Sezen A. Diyaliz Hemşireliği, Nobel Tıp Kitapevi, İstanbul; 2014. s. 296.
• 41. Aydın ŞÖ. Yoğun Bakımda Karşılaşılan Kanama Bozuklukları, http://www.thd.org.tr/thdData/Books/679/yogun-bakimda-karsilasilan-kanama-bozukluklari-seniz-ongoren-aydin.pdf, Erişim: 25.11.2022.
• 42. Tuğçe A, Betül Ö, Kaptan D, Yeter K, Öztürk H. COVID-19 tanısı olan hastanın uluslararası hemşirelik uygulaması sınıflandırma sistemine göre hemşirelik bakımı: olgu sunumu. Güncel Hemşirelik Araştırmaları Dergisi, 2021;(1), 32-43.
• 43. Dağlı DA, Büyükbayram A, Arabacı LB. COVID-19 tanısı alan hasta ve ailesine psikososyal yaklaşım. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 2021; 5(2), 191-195. 44. Dürüst Ç. Covıd-19 Sürecinin Psikososyal Açıdan Değerlendirilmesi. Uluslararası Sosyal Bilimler ve Sanat Araştırmaları, 2021; 1(1), 41-55.
• 45. Engin E. Ruh Sağlığı ve Hastalıkları Hemşireliği (Bakım Sanatı), İstanbul Medikal Yayıncılık, 2014; s.277–309
• 46. Oflaz F. Psikiyatri Hemşireliği İleri Düzey Uygulamalar için Psikoterapi, Ankara Nobel Tıp Kitapevi, Ankara;2020; s.470–495. 47. Azoulay E, Kentish-Barnes N. A 5-point strategy for improved connection with relatives of critically ill patients with COVID-19. The Lancet. Respiratory Medicine, 2020;8(6), e52. doi:10.1016/S2213-2600(20)30223-X
• 48. Back A, Tulsky JA, Arnold RM. Communication skills in the age of COVID-19. Ann Intern Med 2020 Jun 2;172(11):759-760. doi: 10.7326/M20-1376. Epub 2020 Apr 2.